Sabin Vaccine Institute President Dr. Peter Hotez gave the keynote address on NTDs at the Pontifical Council for Health Care Workers’ XXXI International Conference, focused on NTDs and rare diseases.

This article was originally posted on the DSW Blog.

During the month of October, END7 student supporters are celebrating NTD Success Stories — spreading the exciting news that many countries around the world have already made incredible progress towards the control and elimination of some NTDs. In recent weeks, there have been many new successes to celebrate.

In a new editorial published in PLOS NTDs, Sabin Vaccine Institute president Dr.

new study published in Nature Genetics, led by a team of researchers at the Washington University School of Medicine in St. Louis, reveals that the hookworm’s genome has been decoded.

Sabin is happy to announce the arrival of our 2012 Annual Report, featuring highlights from our three programs – Vaccine Advocacy and Education, The Sabin Product Development Partnership, and the Global Network for Neglected Tropical Diseases.

Reposted with permission from the TAMEST blog, which is run by the Academy of Medicine, Engineering & Science of Texas. 

Field research, such as that conducted for clinical trials or disease surveillance, is essential to address the many pervasive health issues in developing countries. It relies on extensive collaboration between research institutions and groups on the ground.

To highlight the extensive body of knowledge collected in developing the Global Vaccine Action Plan (GVAP), the journal Vaccine today released a special supplement dedicated in full to the Decade of Vaccines.

Today marks the first day of vaccinations for Phase I, Part II clinical testing of Sabin's human hookworm vaccine in Brazil.

Pages